Spectrum of Biochemical Derangements in Patients with Covid-19 Infection

Authors

  • Sajjad Ali Haider
  • Zujaja Hina Haroon
  • Athar Iqbal Paracha
  • Muhammad Aamir
  • Saima Bashir
  • Syed Raza Jaffar

DOI:

https://doi.org/10.51985/JBUMDC2023176

Keywords:

COVID-19, Biochemical markers, Severity groups

Abstract

Objectives: To evaluate the biochemical derangements in COVID-19 patients according to disease severity.
Place and Duration of Study: This Cross-Sectional Study was conducted at Chemical Pathology Department of Armed
Forces Institute of Pathology, Rawalpindi from March to August 2021.
Methodology: A total of 996 patients of age between 20 to 75 years admitted at Pak Emirates Military Hospital Rawalpindi
with COVID-19 were selected and further categorized into mild, moderate, and severe groups. Serum samples were collected
and analyzed for various biochemical parameters. A mean comparison of the results of these biochemical markers amongst
three groups was carried out by applying a one-way analysis of variance (ANOVA), p value = 0.05 was statistically
significant.
Results: The values of total bilirubin, ALT, AST, CK, CK MB, troponin I, LDH, urea, creatinine, CRP, PCT, and ferritin
increased with the severity of the disease. Whereas the values of albumin and total protein decreased with the severity of
the disease. The difference in these parameters amongst all three groups was found to be statistically significant with p
value <0.05. However, the values of GGT, total cholesterol, and TG were found non-significant amongst all three groups
(p value>0.05).
Conclusion: Derangement of biochemical parameters increased proportionately with the severity of the disease. Hence
these markers can provide significant assistance to categorize patients into different severity groups as well as monitoring
and prognosis of the disease. In this way, earlier and more accurate medical interventions can be provided to patients for
a better outcome from this pandemic.

References

Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB,

Bernardini S. The COVID-19 pandemic. Critical reviews in

clinical laboratory sciences. 2020;57(6):365-88. https://doi

.org/10.1080/10408363.2020.1783198

Padhan R, Prabheesh KP. The economics of COVID-19

pandemic: A survey. Economic analysis and policy.

;70:220-37. https://doi.org/10.1016/j.eap.2021.02.012

Who.int. Retrieved November 27, 2022, from https:// covid19.

who.int/table

Zheng C, Shao W, Chen X, Zhang B, Wang G, Zhang W.

Real-world effectiveness of COVID-19 vaccines: a literature

review and meta-analysis. International Journal of Infectious

Diseases. 2022;114:252-60. https://doi.org/10.1016 /j.ijid

.2021.11.009

Hafeez A, Ahmad S, Siddqui SA, Ahmad M, Mishra S. A

review of COVID-19 (Coronavirus Disease-2019) diagnosis,

treatments and prevention. Ejmo. 2020;4(2):116-25. DOI:

14744/ejmo.2020.90853

Gajendra S. Spectrum of hematological changes in COVID-

American Journal of Blood Research. 2022;12(1):43.

PMID: 35291254; PMCID: PMC8918700.

Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, Li T, Chen

Q. High expression of ACE2 receptor of 2019-nCoV on the

epithelial cells of oral mucosa. International journal of oral

science. 2020;12(1):1-5. https://doi.org/10.1038/s41368-020-

-x

Ciaccio M, Agnello L. Biochemical biomarkers alterations

in Coronavirus Disease 2019 (COVID-19). Diagnosis.

;7(4):365-72. https://doi.org/10.1515/dx-2020-0057

Javed W, Baqar JB, Abidi SH, Farooq W. Sero-prevalence

findings from metropoles in Pakistan: implications for assessing

COVID-19 prevalence and case-fatality within a dense, urban

working population. medRxiv. 2020:2020-08. https://doi.org

/10.1101/2020.08.13.20173914

Tjendra Y, Al Mana AF, Espejo AP, Akgun Y, Millan NC,

Gomez-Fernandez C, Cray C. Predicting disease severity and

outcome in COVID-19 patients: a review of multiple

biomarkers. Archives of pathology & laboratory medicine.

;144(12):1465-74. https://doi.org/10.5858/arpa.2020-

-SA

Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA,

Somasundaran M, Sullivan JL, Luzuriaga K, Greenough TC,

Choe H. Angiotensin-converting enzyme 2 is a functional

receptor for the SARS coronavirus. Nature. 2003;

(6965):450-4. https://doi.org/10.1038/nature02145

Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell

RNA-seq data analysis on the receptor ACE2 expression

reveals the potential risk of different human organs vulnerable

to 2019-nCoV infection. Frontiers of medicine. 2020;14:185-

https://doi.org/10.1007/s11684-020-0754-0

Mutlu P, Mirici A, Gönlügür U, OZTOPRAK B, Þule ÖZ,

Reþorlu M, AKÇALI A, ÇAKIR DÜ, Doðan CR. Evaluating

the clinical, radiological, microbiological, biochemical

parameters and the treatment response in COVID-19

pneumonia. Journal of Health Sciences and Medicine.

;5(2):544-51. https://doi.org/10.32322/jhsm.1035790

Pourbagheri-Sigaroodi A, Bashash D, Fateh F, Abolghasemi

H. Laboratory findings in COVID-19 diagnosis and prognosis.

Clinica chimica acta. 2020;510:475-82. https://doi.org/10.1016

/j.cca.2020.08.019

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang

J, Liu Y, Wei Y, Yu T. Epidemiological and clinical

characteristics of 99 cases of 2019 novel coronavirus

pneumonia in Wuhan, China: a descriptive study. The lancet.

;395(10223):507-13. https://doi.org/10.1016/S0140-

(20)30211-7

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L,

Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of

coronavirus disease 2019 in China. New England journal of

medicine. 2020;382(18):1708-20. DOI: 10.1056/ NEJMoa

Yang W, Cao Q, Qin LE, Wang X, Cheng Z, Pan A, Dai J,

Sun Q, Zhao F, Qu J, Yan F. Clinical characteristics and

imaging manifestations of the 2019 novel coronavirus disease

(COVID-19): a multi-center study in Wenzhou city, Zhejiang,

China. Journal of Infection. 2020;80(4):388-93. https://doi.

org/10.1016/j.jinf.2020.02.016

Li Y, Hu Y, Yu J, Ma T. Retrospective analysis of laboratory

testing in 54 patients with severe-or critical-type 2019 novel

coronavirus pneumonia. Laboratory investigation.

;100(6):794-800. https://doi.org/10.1038/s41374-020-

-6

Colafrancesco S, Priori R, Alessandri C, Astorri E, Perricone

C, Blank M, Agmon-Levin N, Shoenfeld Y, Valesini G. sCD163

in AOSD: a biomarker for macrophage activation related to

hyperferritinemia. Immunologic research. 2014;60:177-83.

https://doi.org/10.1007/s12026-014-8563-7

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ,

Akdis CA, Gao YD. Clinical characteristics of 140 patients

infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;

(7):1730-41. https://doi.org/10.1111/all.14238

Downloads

Published

2023-04-03

How to Cite

Haider , S. A. ., Haroon, Z. H. ., Paracha, A. I. ., Aamir, M. ., Bashir, S. ., & Jaffar, S. R. (2023). Spectrum of Biochemical Derangements in Patients with Covid-19 Infection. Journal of Bahria University Medical and Dental College, 13(02), 125–129. https://doi.org/10.51985/JBUMDC2023176

Issue

Section

Original Articles